Altria Group Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
4.0%projected annual EPS growth
Analyst Coverage
11analysts covering
FY EPS (est.)
$5.68next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Conference Call | 29 Oct 2026 |
Monitoring Framework
Key Performance Indicators
U.S. Smoke-Free Net Revenues Annually2.6BTarget: $5 billion by 2028 (currently under reassessment due to illicit e-vapor market dynamics)
Adjusted Diluted EPS CAGR (from 2022 base of $4.87) Annually0.0Target: Mid-single digits compounded annual growth rate through 2028
Total Adjusted Operating Companies Income (OCI) Margin Quarterly65.1%Target: At least 60% in each year through 2028
Debt-to-Consolidated EBITDA Ratio Annually210.0%Target: Approximately 2.0x
Watch Items
- Illicit E-Vapor Market ProliferationTrigger: Illicit products representing more than 60% of the e-vapor categoryAction: Monitor federal and state enforcement actions (e.g., FDA and DEA joint operations) and reassess long-term smoke-free volume and revenue goals.
- Combustible Cigarette Volume Decline RateTrigger: Domestic cigarette shipment volume decline exceeding the historical industry average of 5-6%Action: Evaluate net price realization strategies and premium brand market share stability (Marlboro) to defend smokeable segment OCI.
- Oral Nicotine Category Expansion (on! brand)Trigger: Slowing of on! volume growth below double-digit percentagesAction: Assess promotional spending, competitive dynamics against ZYN, and international expansion pathways (e.g., on! PLUS in Sweden and the UK).
Research as of 2 Sep 2026